Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
ARS
2022 FY
Annual report to shareholders
8 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
30 Mar 22
Current reports
8-K
Entry into a Material Definitive Agreement
27 Mar 24
8-K
Entry into a Material Definitive Agreement
22 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Nov 23
8-K
Entry into a Material Definitive Agreement
13 Oct 23
8-K
Departure of Directors or Certain Officers
13 Oct 23
8-K
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
5 Sep 23
8-K
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
21 Aug 23
8-K
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
24 Jul 23
8-K
Regulation FD Disclosure
19 Jul 23
8-K
Entry into a Material Definitive Agreement
7 Jul 23
Registration and prospectus
D
$700.00 k in Convertible Debt, sold $700.00 k, 2 investors
20 Oct 23
424B3
Prospectus supplement
29 Jun 23
S-3
Shelf registration
16 Jun 23
RW
Registration withdrawal request
22 Mar 23
S-3
Shelf registration
28 Jun 22
S-8
Registration of securities for employees
8 Dec 20
424B5
Prospectus supplement for primary offering
7 Apr 20
424B5
Prospectus supplement for primary offering
6 Apr 20
424B5
Prospectus supplement for primary offering
13 Dec 19
424B2
Prospectus for primary offering
26 Apr 19
Proxies
DEF 14A
Definitive proxy
8 Sep 23
PRE 14A
Preliminary proxy
29 Aug 23
DEFA14A
Additional proxy soliciting materials
12 Dec 22
DEF 14C
Information statement
25 Nov 22
DEF 14A
Definitive proxy
21 Nov 22
PRE 14C
Preliminary information
14 Nov 22
DEF 14A
Definitive proxy
13 Dec 21
PRER14A
Preliminary revised proxy
7 Dec 21
PRER14A
Preliminary revised proxy
3 Dec 21
PRER14A
Preliminary revised proxy
24 Nov 21
Other
EFFECT
Notice of effectiveness
29 Jun 23
CORRESP
Correspondence with SEC
27 Jun 23
UPLOAD
Letter from SEC
22 Jun 23
CERT
Certification of approval for exchange listing
2 Nov 18
EFFECT
Notice of effectiveness
10 Aug 18
CORRESP
Correspondence with SEC
8 Aug 18
CORRESP
Correspondence with SEC
8 Aug 18
UPLOAD
Letter from SEC
3 May 18
EFFECT
Notice of effectiveness
10 Aug 17
CORRESP
Correspondence with SEC
8 Aug 17